These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1547691)

  • 1. Advanced glycosylation end products (AGE) and diabetic nephropathy.
    Brouhard BH
    Diabetes Care; 1992 Feb; 15(2):302-3. PubMed ID: 1547691
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced glycosylation end products in patients with diabetic nephropathy.
    Makita Z; Radoff S; Rayfield EJ; Yang Z; Skolnik E; Delaney V; Friedman EA; Cerami A; Vlassara H
    N Engl J Med; 1991 Sep; 325(12):836-42. PubMed ID: 1875967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cells and type VIII collagen in human diabetic nephropathy.
    Rüger BM; Hasan Q; Greenhill NS; Davis PF; Dunbar PR; Neale TJ
    Diabetologia; 1996 Oct; 39(10):1215-22. PubMed ID: 8897010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
    Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
    Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical detection of advanced glycosylation end products in vivo.
    Makita Z; Vlassara H; Cerami A; Bucala R
    J Biol Chem; 1992 Mar; 267(8):5133-8. PubMed ID: 1371995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased non-enzymatic glycosylation and reduced solubility of skin collagen in insulin-dependent diabetic patients.
    Salmela PI; Oikarinen A; Pirttiaho H; Knip M; Niemi M; Ryhänen L
    Diabetes Res; 1989 Jul; 11(3):115-20. PubMed ID: 2627762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy.
    Gordin D; Shah H; Shinjo T; St-Louis R; Qi W; Park K; Paniagua SM; Pober DM; Wu IH; Bahnam V; Brissett MJ; Tinsley LJ; Dreyfuss JM; Pan H; Dong Y; Niewczas MA; Amenta P; Sadowski T; Kannt A; Keenan HA; King GL
    Diabetes Care; 2019 Jul; 42(7):1263-1273. PubMed ID: 31076418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes.
    Beisswenger PJ; Makita Z; Curphey TJ; Moore LL; Jean S; Brinck-Johnsen T; Bucala R; Vlassara H
    Diabetes; 1995 Jul; 44(7):824-9. PubMed ID: 7789650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic collagen alterations in human diabetes mellitus. Changes in basement membrane collagen content and in the susceptibility of total collagen to cyanogen bromide solubilisation.
    Rasmussen LM; Ledet T
    Diabetologia; 1993 May; 36(5):445-53. PubMed ID: 8314450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
    van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
    Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in diabetic nephropathy: how big a culprit is glucose?
    Striker GE; Striker LJ
    Diabetes Metab; 1996 Dec; 22(6):407-14. PubMed ID: 8985648
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-enzymatic glycosylation of immunoglobulins in diabetic nephropathy.
    Kalia K; Sharma S; Mistry K
    Clin Chim Acta; 2004 Sep; 347(1-2):169-76. PubMed ID: 15313155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy.
    Yokoyama H; Høyer PE; Hansen PM; van den Born J; Jensen T; Berden JH; Deckert T; Garbarsch C
    Diabetes; 1997 Nov; 46(11):1875-80. PubMed ID: 9356039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.
    Beisswenger PJ; Moore LL; Brinck-Johnsen T; Curphey TJ
    J Clin Invest; 1993 Jul; 92(1):212-7. PubMed ID: 8325987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
    Tsuchida K; Makita Z; Yamagishi S; Atsumi T; Miyoshi H; Obara S; Ishida M; Ishikawa S; Yasumura K; Koike T
    Diabetologia; 1999 May; 42(5):579-88. PubMed ID: 10333051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?
    McLennan SV; Kelly DJ; Schache M; Waltham M; Dy V; Langham RG; Yue DK; Gilbert RE
    Kidney Int; 2007 Aug; 72(4):481-8. PubMed ID: 17554258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossline levels in serum and erythrocyte membrane proteins from patients with diabetic nephropathy.
    Aoki S; Hasegawa G; Shigeta H; Obayashi H; Fujii M; Kimura F; Moriwaki A; Nakamura N; Ienaga K; Nakamura K; Kondo M
    Diabetes Res Clin Pract; 2000 May; 48(2):119-25. PubMed ID: 10802149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interventional possibilities in diabetic nephropathy].
    Jungmann E
    Fortschr Med; 1993 Oct; 111(29):451-2. PubMed ID: 8258420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.